3rd Quarter - Report

ACG ADVOCACY for GENENTECH INC

Period 3rd Quarter 2020 Filed Oct 20, 2020 Signed by Shawn H. Smeallie

Official filing
Firm
ACG ADVOCACY
Client
GENENTECH INC
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade Negotiations. Trade Policy Issues.

LobbyistCovered position, as disclosed
DANA COLARULLI —
CHRIS ISRAEL —
DAVID J URBAN —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); White House Office; SENATE

Copyright/Patent/Trademark CPT

General IP Issues. Patent Litigation Reform.

LobbyistCovered position, as disclosed
DANA COLARULLI Director, Government Affairs PTO
CHRIS ISRAEL U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce.
DAVID J URBAN Chief of Staff, Senator Arlen Specter

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; White House Office

Pharmacy PHA

Drug Pricing Issues. Public Health Crisis. H.R.748/S.3548: Coronavirus Aid, Relief, and Economic Security Act or the CARES Act.

LobbyistCovered position, as disclosed
CHRIS ISRAEL —
DAVID J URBAN —

Contacted: White House Office; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3548 (116th), H.R. 748 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.